Cargando…

Neopterin as a Marker of In-Stent Restenosis: to Have or Have Not

Detalles Bibliográficos
Autor principal:	Nishihira, Kensaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224200/ https://www.ncbi.nlm.nih.gov/pubmed/29794395 http://dx.doi.org/10.5551/jat.ED097

Ejemplares similares

The emerging utility of neopterin?
por: Beigel, John
Publicado: (2005)

Does Lipoprotein (a) Level Have a Predictive Value in Restenosis after Coronary Stenting?
por: Khosravi, Alireza, et al.
Publicado: (2011)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
por: Wasser, Katrin, et al.
Publicado: (2011)

Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?
por: Arroyo, Diego, et al.
Publicado: (2021)

In-Stent Restenosis: Chasing Our Tails in Search of a Solution
por: Lahmann, Anna Lena, et al.
Publicado: (2020)

State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
por: Byrne, Robert A., et al.
Publicado: (2015)

Histopathology of Asymptomatic Iliac Atherosclerosis: From Autopsy to Practice
por: Nishihira, Kensaku, et al.
Publicado: (2017)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Side marker creep: have radiographers changed their side marker habits?
por: Fuller, Michael
Publicado: (2016)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Peri-Contrast Staining as a Marker of Stent Failure: Restenosis, Thrombosis, and Fracture
por: Mshelbwala, Fakilahyel S., et al.
Publicado: (2021)

Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease
por: Gabbasov, Zufar, et al.
Publicado: (2018)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

To Have and Have Not: Intrinsic Platelet Hyperreactivity?
por: Laine, Marc, et al.
Publicado: (2018)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

‘Miracle stents’ - a future without restenosis
por: Hamid, Huda, et al.
Publicado: (2007)

Pathological findings of a distal embolus during laser atherectomy for in-stent occlusion of the superficial femoral artery
por: Ogata, Kenji, et al.
Publicado: (2023)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020)

Comparison between plasma neopterin and the urine neopterin:creatinine ratio as inflammatory biomarkers
por: Thomas, Bianca, et al.
Publicado: (2019)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Hyperglycemia Drives Stent Restenosis in STEMI Patients
por: Mone, Pasquale, et al.
Publicado: (2021)

Neopterin and Cardiovascular Events Following Coronary Stent Implantation in Patients with Stable Angina Pectoris
por: Yoshiyama, Tomotaka, et al.
Publicado: (2018)

A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
por: Ucar, Fatih Mehmet
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jkmg9nvh79cbslb6fkohqpcnbk